Genetic polymorphism in msp-2, ama-1 and csp genes in Plasmodium falciparum field isolates from north and north-western India

Journal of Vector Borne Diseases

Volumn 46, Issue 2, 2009, Pages 109-116

  Farooq, Umar ^a   Malla, N ^a   Dubey, M L ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Ama 1; csp; Genetic polymorphism; msp 2; Nested PCR; PCR RFLP; Plasmodium falciparum

Indexed keywords

3D7 ANTIGEN; AMA 1 ANTIGEN; BACTERIAL ANTIGEN; CSP ANTIGEN; ENDONUCLEASE; FC 27 ANTIGEN; MSP 2 ANTIGEN; PROTEIN DRA 1; PROTEIN HINF I; PROTEIN SSP 1; UNCLASSIFIED DRUG; APICAL MEMBRANE ANTIGEN I, PLASMODIUM; CIRCUMSPOROZOITE PROTEIN, PROTOZOAN; MALARIA VACCINE; MEMBRANE PROTEIN; PARASITE ANTIGEN; PROTOZOAL DNA; PROTOZOAL PROTEIN;

ALLELE; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; DNA EXTRACTION; GENE TARGETING; GENETIC POLYMORPHISM; GENETIC VARIABILITY; INDIA; NONHUMAN; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ANIMAL; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; PARASITOLOGY;

ALLELES; ANIMALS; ANTIGENS, PROTOZOAN; DNA, PROTOZOAN; HUMANS; INDIA; MALARIA VACCINES; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTOZOAN PROTEINS;

EID: 67649761105     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Snow RW, Korenromp EL, Gouws E. Paediatric mortality in Africa: Plasmodium falciparum malaria as a cause or risk? Am J Trop Med Hyg 2004; 71(Suppl 2): 16-24.
2. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434: 214-7.
3. Sharma VP. Drug resistance: mechanism and management. Singhal Radhey L, Sood OP, editors. New Delhi, India: Ranbaxy Science Foundation 1997; p. 67-72.
4. Hastings IM, D'Alessandro U. Modeling a predictable disaster: the rise and spread of drug resistant malaria. Parasitol Today 2000; 16: 340-7.
5. Pickard AL, Wernsdorfer WH. Epidemiology of drug resistant malaria. Lancet Infect Dis 2002; 2: 209-18.
6. Umar Farooq, Mahajan RC. Drug resistance in malaria. J Vector Borne Dis 2004; 41: 45-53.
7. Tanabe K, Mackay M, Goman M, Scaife JG. Allelic dimorphism in a surface antigen gene of the malaria parasite, P. falciparum. J Mol Biol 1987; 195: 273-87.
8. Smythe JA, Coppel RL, Brown GV, Ramasamy R, Kemp DJ, Anders RF. Identification of two integral membrane proteins of P. falciparum. Proc Natl Acad Sci USA 1988; 85: 51995-9.
9. Oliveira DA, Udhayakumar V, Bloland PB, Shi YP, Nahlen BL, Oloo AJ, et al. Genetic conservation of the P. falciparum apical membrane antigen-1 (AMA-1). Mol Biochem Parasitol 1996; 76: 333-6.
10. Engers HD, Godal T. Malaria vaccine development: current status. Parasitol Today 1998; 14: 56-64.
11. Miller LH, Roberts T, Shahabuddin M, McChutchan TF. Analysis of sequence diversity in the P. falciparum merozoite surface protein-1 (MSP-1). Mol Biochem Parasitol 1993: 59: 1-14
12. Genton B, Betuela I, Felger I, Al-Yaman F, Anders AF, Saul A, et al. A recombinant blood stage vaccine reduced P. falciparum density and exerts selective pressure on parasite population in Phase 1-2b trial in Papua New Guinea. J Infect Dis 2002; 85: 820-7.
13. Collins WE, Pye D, Crewter PE, Vandenberg KL, Galland GG, Sulzer AJ, et al. Protective immunity induced in squirrel, monkeys with recombinant apical membrane antigen-1 of P. fragile. Am J Trop Med Hyg 1994; 51: 711-9
14. Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. New Eng J Med 1997; 336: 86-91.
15. Mahajan RC, Umar Farooq, Dubey ML, Malla N. Genetic polymorphism in Plasmodium falciparum vaccine candidate antigens. Indian J Path Microbiol 2005; 48: 429-38.
16. Farooq Umar, Dubey ML, Malla N, Mahajan RC. Plasmodium falciparum: polymorphism in msp-1 gene of isolates from India and predominance of certain alleles in cerebral malaria. Exp Parasitol 2006; 112: 139-43.
17. Bhattacharya PR. Genetic polymorphism in T-cell epitopes of the circumsporozoite protein of Plasmodium falciparum clones and isolates from India. Trans R Soc Trop Med Hyg 1999; 93: 204-7.
18. Joshi H, Valecha N, Verma A, Kaul A, Mallick PK, Shalini S, et al. Genetic structure of Plasmodium falciparum field isolates in eastern and north-eastern India. Malar J 2007; 6: 60.
19. Bhattacharya PR, Kumar M, Das RH. Surprisingly little polymorphism in the merozoite surface protein-2 (MSP-2) gene of Indian Plasmodium falciparum. Ann Trop Med Parasitol 1999; 93: 561-4.
20. Ranjit MR, Das A, Das BP, Das BN, Dash BP, Chhotray GP. Distribution of Plasmodium falciparum genotypes in clinically mild and severe malaria cases in Orissa, India. Trans R Soc Trop Med Hyg 2005, 99: 389-95.
21. Smythe JA, Coppel RL, Day KP, Martin RK, Oduola AM, Kemp DJ, et al. Structural diversity in the P. falciparum MSA-2. Proc Natl Acad Sci USA 1991; 88: 1751-5.
22. Laserson KF, Petralanda I, Hamlin DM, Almera R, Fuentes M, Carrasquel A, et al. Use of the polymerase chain reaction to directly detect malaria parasites in blood samples from the Venezuelan Amazon. Am J Trop Med Hyg 1994; 50: 169-80.
23. Foley M, Ranford Cartwright-LC, Babiker HA. Rapid and simple method for isolating malaria DNA from finger prick samples of blood. Mol Biochem Parasitol 1992; 53: 241-4.
24. Zwetyenga J, Rogier C, Tall A, Fontienille D, Snounou G, Trape JF, et al. No influence of age on infection complexity and allelic distribution in P. falciparum infection in Ndiop, a Senegalese village with seasonal mesoendemic malaria. Am J Trop Med Hyg 1998; 59: 726-35.
25. Marshall VM, Zhang LX, Anders RF, Coppel RL. Diversity of vaccine candidate AMA-1 of P. falciparum. Mol Biochem Parasitol 1996; 77: 109-13.
26. Yoshida N, Silvia M, Di Santi, Dutra AP, Nussenzweig RS, Nussenzweig V, et al. Plasmodium falciparum: Restricted polymorphism of T-cell epitopes of the circumsporozoite protein in Brazil. Exp Parasitol 1990; 71: 386-92.
27. Felger I, Tavul L, Kabintik S, Marshal V, Genton B, Alpers M, et al. P. falciparum extensive polymorphism in MSP-2 in an area with endemic malaria in Papua New Guinea. Exp Parasitol 1994; 79: 106-16.
28. Tibayrenc M, Kjelberg F, Ayala FJ. Clonal theory of parasite protozoan: the population structures of Entamoeba, Giardia, Leishmania, Neagleria, Plasmodium, Trichomonas and Trypanosoma and their medical and taxonomical consequences. Proc Natl Acad Sci USA 1990; 87: 2414-8.
29. Viriyakosol S, Siripoon N, Petcharapirat C, Petcharapirat P, Jarra W, Thaitong S, et al. Genotyping of P. falciparum isolates by PCR and potential uses in epidemiological studies. Bull WHO 1995; 73: 85-95.
30. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, et al. Biased distribution of msp-1 and msp-2 allelic variants in Plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg 1999; 93: 369-74.
31. Eisen DP, Marshall VM, Billman JH, Coppel RL, A Plasmodium falciparum apical membrane antigen-1 (AMA-1) gene apparently generated by intragenic recombination. Mol Biochem Parasitol 1999; 100: 243-6.
32. Escalante AA, Grebert HM, Chaiyaroj SC, Magris M, Biswas S, Nahlen BK, et al. Polymorphism in the gene encoding the apical membrane antigen-1 (AMA-1) of Plasmodium falciparum, X. Asembo Bay Cohort Project. Mol Biochem Parasitol 2001; 113: 279-87.
33. Chenet SM, Branch OH, Escalante AA, Lucas CM, Bacon DJ. Genetic diversity of vaccine candidate antigens in Plasmodium falciparum isolates from the Amazon basin of Peru. Malar J 2008; 7: 93.
34. Sidhu AB, Madhubala RP. P. falciparum detection and strain identification of Indian isolates by PCR. South-east Asian J Trop Med Public Health 2000; 31: 213-8.
35. Doolan DL, Saul AJ, Good MF. Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development. Infect Immun 1992; 60: 675-82.
36. Lockyer MJ, Marsh K, Newbold CI. Wild isolates of P. falciparum show extensive polymorphism in T-cell epitopes of the CS protein. Mol Biochem Parasitol 1989; 37: 275-80.
37. Ranjit MR, Sharma YD. Genetic polymorphism of falciparum malaria vaccine candidate antigen genes among field isolates in India. Am J Trop Med Hyg 1999; 61: 103-8.
38. Dolmazon V, Matsika-Claquin MD, Manirakiza A, Yapou F, Nambot M, et al. Genetic diversity and genotype multiplicity of Plasmodium falciparum infections in symptomatic individuals living in Bangui (CAR). Acta Trop 2008; 107: 37-42.
39. Babiker HA, Abdel-Muhsin AA, Hamad A, Mackinnon MJ, Hill WG, Walliker D. Population dynamics of Plasmodium falciparum in an unstable malaria area of eastern Sudan. Parasitol 2000; 120: 105-11.
40. Ariey F, Chalvet W, Hommel D, Peneau C, Hulin A, Mercereau-Puijalon O, et al. Plasmodium falciparum parasites in French Guyana: limited genetic diversity and high selfing rate. Am J Trop Med Hyg 1999; 61: 978-85.
41. Montoya L, Maestre A, Carmona J, Lopes D, Do Rosario V, Blair S. Plasmodium falciparum: diversity studies of isolates from two Colombian regions with different endemicity. Exp Parasitol 2003; 104: 14.
42. Felger I, Smith T, Edok D, Kitua A, Alonso P, Tanner M, Beck HP. Multiple P. falciparum infections in Tanzanian infants. Trans R Soc Trop Med Hyg 1999; S1: 29-34.
43. Conway DJ, Greenwood BM, McBride JS. The epidemiology of multiple clone P. falciparum infection in Gambian patients. Parasitol 1991; 103: 1-6.
44. Ntoumi F, Contamin H, Rogier C, Bonnefoy S, Trape JF, Mercureau-Puijalon O. Age dependent carriage of multiple Plasmodium falciparum MSP-2 alleles in symptomatic malaria infections. Am J Trop Med Hyg 1995; 52:81-8.
45. Haddad D, Snounou G, Mattei D, Enamorado IG, Figueroa J, Stahl S, et al. Limited genetic diversity of Plasmodium falciparum in field isolates from Honduras. Am J Trop Med Hyg 1999; 60: 30-4.
46. Bhattacharya P, Malhotra PR, Sharma P, Okenu DMN, Chauhan VS. Merozoite surface antigen-2 (MSA-2) gene of P. falciparum strains from India. Mol Biochem Parasitol 1995; 574: 125-7.